Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6767032rdf:typepubmed:Citationlld:pubmed
pubmed-article:6767032lifeskim:mentionsumls-concept:C0002771lld:lifeskim
pubmed-article:6767032lifeskim:mentionsumls-concept:C0027410lld:lifeskim
pubmed-article:6767032pubmed:issue2lld:pubmed
pubmed-article:6767032pubmed:dateCreated1980-5-23lld:pubmed
pubmed-article:6767032pubmed:abstractTextA series of 8-alkyl-3-methoxy-17-methylmorphinan-6-ones (3C) and -isomorphinan-6-ones (3T) were prepared by conjugate addition of lithium dialkylcuprates to the corresponding 7,8-didehydro-6-ones 2C and 2T. These 17-methyl compounds were potent analgesics and were converted to mixed narcotic agonists-antagonists 7-10, by replacement of the 17-methyl groups with cycloalkylmethyl moieties. The 8 substituent modified the type of activity observed. One of these compounds, 17-(cyclobutylmethyl)-3-hydroxy-8 beta-methylmorphinan-6-one (10Ca), had an agonist-antagonist ratio of 0.1. Compound 10Ca did not support or cause dependence in rats. This compound, however, appeared to be a typical narcotic agent in morphine-dependent monkeys.lld:pubmed
pubmed-article:6767032pubmed:languageenglld:pubmed
pubmed-article:6767032pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6767032pubmed:citationSubsetIMlld:pubmed
pubmed-article:6767032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6767032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6767032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6767032pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6767032pubmed:statusMEDLINElld:pubmed
pubmed-article:6767032pubmed:monthFeblld:pubmed
pubmed-article:6767032pubmed:issn0022-2623lld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:RazdanR KRKlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:HowesJ FJFlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:KotickM PMPlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:SchutR NRNlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:PolazziJ OJOlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:OsgoodP FPFlld:pubmed
pubmed-article:6767032pubmed:authorpubmed-author:VillarrealJ...lld:pubmed
pubmed-article:6767032pubmed:issnTypePrintlld:pubmed
pubmed-article:6767032pubmed:volume23lld:pubmed
pubmed-article:6767032pubmed:ownerNLMlld:pubmed
pubmed-article:6767032pubmed:authorsCompleteYlld:pubmed
pubmed-article:6767032pubmed:pagination174-9lld:pubmed
pubmed-article:6767032pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:meshHeadingpubmed-meshheading:6767032-...lld:pubmed
pubmed-article:6767032pubmed:year1980lld:pubmed
pubmed-article:6767032pubmed:articleTitleAnalgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones.lld:pubmed
pubmed-article:6767032pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6767032lld:chembl